Literature DB >> 7672618

Pseudophakic retinal detachment: anatomic and visual results.

P Girard, I Karpouzas.   

Abstract

BACKGROUND: Our purpose was to report the anatomic and visual results of pseudophakic retinal detachment surgery in a large series of consecutive cases and to analyze the risk factors for anatomic and functional failure.
METHODS: This retrospective study covered 290 primary cases of idiopathic rhegmatogenous retinal detachment operated on by the same surgeon during an 8-year period. Data relating to 26 pre-, per-, and postoperative variables were studied. For the statistical analyses we used both Chi-square and stepwise logistic regression tests.
RESULTS: Vitreous loss occurred in 56 cases (19.3%), and the retina detached more than 2 years after lens extraction in 108 cases (37.2%). Breaks could be identified in 249 cases (85.8%), and the macula was involved in 235 (81%). The overall reattachment rate was 85.2% (247/290), and a postoperative visual acuity of 0.5 D or more was attained in 49.6% of cases (144/290). We found no difference between phakoemulsification, extracapsular, intracapsular techniques or between anterior chamber, posterior chamber, iris-fixated lenses as regards anatomic and functional outcomes. Proliferative vitreoretinopathy (PVR) and photoreceptor dysfunction were the main causes of anatomic and functional failure respectively. We identified extensive detachment, preoperative choroidal detachment, intraoperative hemorrhage and surgery for PVR as predictors of anatomic failure, while preoperative inflammation, preoperative PVR of grade B or worse, and surgery for PVR were predictors of functional failure.
CONCLUSION: In this series, anatomic and visual results of reattachment surgery were much more affected by detachment features and by PVR than by the techniques and complications of cataract surgery.

Entities:  

Mesh:

Year:  1995        PMID: 7672618     DOI: 10.1007/bf00200480

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  Pseudophakic retinal detachments. Anatomic and visual results.

Authors:  C M Greven; R J Sanders; G C Brown; W H Annesley; L K Sarin; W Tasman; T M Morgan
Journal:  Ophthalmology       Date:  1992-02       Impact factor: 12.079

2.  [Retinal detachment in pseudophakia. Analysis of 164 cases].

Authors:  P Colliac; M Labetoulle; B Ameline; C Morel; J Haut
Journal:  J Fr Ophtalmol       Date:  1992       Impact factor: 0.818

3.  Pars plana vitrectomy for the treatment of rhegmatogenous retinal detachment uncomplicated by advanced proliferative vitreoretinopathy.

Authors:  D S Gartry; A H Chignell; W A Franks; D Wong
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

4.  Perioperative choroidal hemorrhage at pars plana vitrectomy. A case-control study.

Authors:  J G Piper; D P Han; G W Abrams; W F Mieler
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

5.  Pseudophakic retinal detachments.

Authors:  C P Wilkinson
Journal:  Retina       Date:  1985 Winter-Spring       Impact factor: 4.256

6.  Retinal detachment after cataract surgery. Surgical results.

Authors:  A Yoshida; H Ogasawara; A E Jalkh; R J Sanders; J W McMeel; C L Schepens
Journal:  Ophthalmology       Date:  1992-03       Impact factor: 12.079

7.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

8.  Primary vitrectomy for rhegmatogenous retinal detachment.

Authors:  K N Hakin; M J Lavin; P K Leaver
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

9.  Wound complications in pars plana vitrectomy.

Authors:  A E Kreiger
Journal:  Retina       Date:  1993       Impact factor: 4.256

10.  A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling.

Authors:  W S Grizzard; G F Hilton; M E Hammer; D Taren
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

View more
  7 in total

1.  Surgical outcomes for primary rhegmatogenous retinal detachments in patients with pseudophakia after phacoemulsification.

Authors:  Ji Won Lim; Soo Jeong Ryu
Journal:  Korean J Ophthalmol       Date:  2011-11-22

2.  Results of scleral buckling operations in primary rhegmatogenous retinal detachment.

Authors:  E C La Heij; P F Derhaag; F Hendrikse
Journal:  Doc Ophthalmol       Date:  2000       Impact factor: 2.379

3.  A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery.

Authors:  Eva Brillat; Frédéric Rouberol; Karine Palombi; Jean-Louis Quesada; Diane Bernheim; Pierre Albaladejo; Florent Aptel; Jean-Paul Romanet; Christophe Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-11       Impact factor: 3.117

4.  Characteristics of rhegmatogenous retinal detachment and their relationship to visual outcome.

Authors:  T H Williamson; M Shunmugam; I Rodrigues; M Dogramaci; E Lee
Journal:  Eye (Lond)       Date:  2013-06-21       Impact factor: 3.775

5.  Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2.

Authors:  Nicolas Feltgen; Claudia Weiss; Sebastian Wolf; Dominique Ottenberg; Heinrich Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-21       Impact factor: 3.535

6.  Visual and anatomic outcomes of vitreoretinal surgery: results at the Boston VA and a review of the literature.

Authors:  Nicole C Hanley-Williams; Manju L Subramanian; Edward B Feinberg
Journal:  Digit J Ophthalmol       Date:  2009-03-17

7.  Scleral buckling versus vitrectomy for macula-off rhegmatogenous retinal detachment as accessed with spectral-domain optical coherence tomography: a retrospective observational case series.

Authors:  Chunmei Huang; Te Fu; Tonghe Zhang; Xinyi Wu; Qiang Ji; Ruili Tan
Journal:  BMC Ophthalmol       Date:  2013-04-15       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.